516 related articles for article (PubMed ID: 27276986)
41. Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study.
Zhang L; Xiao Y; Zhang G; Li H; Zhao J; Chen M; Chen F; Liu L; Li Y; Peng L; Zhao F; Yang D; Wen Z; Wu L; Wu S; Sun Y; Wang Y; Chen L; Wang X; Wang L; Li W; Qiu H; Chen Y; Gao Z; Ren L; Wang J
BMC Infect Dis; 2023 Apr; 23(1):231. PubMed ID: 37059987
[TBL] [Abstract][Full Text] [Related]
42. [Lower tract infections as potential indication for therapy with macrolides].
Jahnz-Rózyk K; Targowski T
Pol Merkur Lekarski; 2008 Nov; 25(149):426-8. PubMed ID: 19177781
[TBL] [Abstract][Full Text] [Related]
43. Epidemiology of severe pneumonia caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-year, population-based surveillance for severe pneumonia in Thailand.
Phares CR; Wangroongsarb P; Chantra S; Paveenkitiporn W; Tondella ML; Benson RF; Thacker WL; Fields BS; Moore MR; Fischer J; Dowell SF; Olsen SJ
Clin Infect Dis; 2007 Dec; 45(12):e147-55. PubMed ID: 18190309
[TBL] [Abstract][Full Text] [Related]
44. The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review.
Torres A; Blasi F; Peetermans WE; Viegi G; Welte T
Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1065-79. PubMed ID: 24532008
[TBL] [Abstract][Full Text] [Related]
45. A worldwide perspective of atypical pathogens in community-acquired pneumonia.
Arnold FW; Summersgill JT; Lajoie AS; Peyrani P; Marrie TJ; Rossi P; Blasi F; Fernandez P; File TM; Rello J; Menendez R; Marzoratti L; Luna CM; Ramirez JA;
Am J Respir Crit Care Med; 2007 May; 175(10):1086-93. PubMed ID: 17332485
[TBL] [Abstract][Full Text] [Related]
46. Etiological agents of community-acquired pneumonia in adult patients in Turkey; a multicentric, cross-sectional study.
Köksal I; Ozlü T; Bayraktar O; Yılmaz G; Bülbül Y; Oztuna F; Caylan R; Aydın K; Sucu N;
Tuberk Toraks; 2010; 58(2):119-27. PubMed ID: 20865563
[TBL] [Abstract][Full Text] [Related]
47. Single tube real time PCR for detection of Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydophila pneumoniae and Legionella pneumophila from clinical samples of CAP.
Nomanpour B; Ghodousi A; Babaei T; Jafari S; Feizabadi MM
Acta Microbiol Immunol Hung; 2012 Jun; 59(2):171-84. PubMed ID: 22750778
[TBL] [Abstract][Full Text] [Related]
48. Atypical pneumonia.
J Assoc Physicians India; 2013 Jul; 61(7 Suppl):28-31. PubMed ID: 24779155
[No Abstract] [Full Text] [Related]
49. [Determination of serologic markers against bacterial atypical pneumonia agents in pneumonia patients].
Pinar A; Ercis S; Ulukavak T; Dursun B; Hasçelik G
Mikrobiyol Bul; 2004; 38(1-2):27-32. PubMed ID: 15293899
[TBL] [Abstract][Full Text] [Related]
50. Prospective study of community-acquired pneumonia of bacterial etiology in adults.
Sopena N; Sabrià M; Pedro-Botet ML; Manterola JM; Matas L; Domínguez J; Modol JM; Tudela P; Ausina V; Foz M
Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):852-8. PubMed ID: 10691195
[TBL] [Abstract][Full Text] [Related]
51. Predicting Mycoplasma pneumoniae and Chlamydophila pneumoniae in community-acquired pneumonia (CAP) pneumonia: epidemiological study of respiratory tract infection using multiplex PCR assays.
Ishimaru N; Suzuki S; Shimokawa T; Akashi Y; Takeuchi Y; Ueda A; Kinami S; Ohnishi H; Suzuki H; Tokuda Y; Maeno T
Intern Emerg Med; 2021 Nov; 16(8):2129-2137. PubMed ID: 33983474
[TBL] [Abstract][Full Text] [Related]
52. Aetiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway.
Røysted W; Simonsen Ø; Jenkins A; Sarjomaa M; Svendsen MV; Ragnhildstveit E; Tveten Y; Kanestrøm A; Waage H; Ringstad J
Clin Respir J; 2016 Nov; 10(6):756-764. PubMed ID: 25764275
[TBL] [Abstract][Full Text] [Related]
53. C-reactive protein for discriminating treatment failure from slow responding pneumonia.
Ruiz-González A; Falguera M; Porcel JM; Martínez-Alonso M; Cabezas P; Geijo P; Boixeda R; Dueñas C; Armengou A; Capdevila JA; Serrano R
Eur J Intern Med; 2010 Dec; 21(6):548-52. PubMed ID: 21111942
[TBL] [Abstract][Full Text] [Related]
54. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.
Lim WS; Macfarlane JT; Boswell TC; Harrison TG; Rose D; Leinonen M; Saikku P
Thorax; 2001 Apr; 56(4):296-301. PubMed ID: 11254821
[TBL] [Abstract][Full Text] [Related]
55. Guidelines for community-acquired pneumonia in the ICU.
Wilkinson M; Woodhead MA
Curr Opin Crit Care; 2004 Feb; 10(1):59-64. PubMed ID: 15166851
[TBL] [Abstract][Full Text] [Related]
56. [Pay attention to new evolution trends in the etiology of community-acquired pneumonia in adults].
He LX
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jun; 47(6):576-581. PubMed ID: 38858211
[TBL] [Abstract][Full Text] [Related]
57. Atypical pathogen infection in community-acquired pneumonia.
Yu Y; Fei A
Biosci Trends; 2016 Feb; 10(1):7-13. PubMed ID: 26961211
[TBL] [Abstract][Full Text] [Related]
58. Etiologies and treatment outcomes in patients hospitalized with community-acquired pneumonia (CAP) at Srinagarind Hospital, Khon Kaen, Thailand.
Reechaipichitkul W; Lulitanond V; Tantiwong P; Saelee R; Pisprasert V
Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):156-61. PubMed ID: 15906660
[TBL] [Abstract][Full Text] [Related]
59. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens.
Song JH; Oh WS; Kang CI; Chung DR; Peck KR; Ko KS; Yeom JS; Kim CK; Kim SW; Chang HH; Kim YS; Jung SI; Tong Z; Wang Q; Huang SG; Liu JW; Lalitha MK; Tan BH; Van PH; Carlos CC; So T;
Int J Antimicrob Agents; 2008 Feb; 31(2):107-14. PubMed ID: 18162378
[TBL] [Abstract][Full Text] [Related]
60. Atypical pneumonia.
Basarab M; Macrae MB; Curtis CM
Curr Opin Pulm Med; 2014 May; 20(3):247-51. PubMed ID: 24626238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
